Viral escape, ®rst characterized for the lymphocytic choriomeningitis virus (LCMV) in a mouse transgenic for the P14 T cell-receptor (TCR), can be due to mutations in T-cell epitopes. We have measured the af®-nity between the H-2D b containing the wild-type and two of its``viral escape'' epitopes, as well as other altered peptide ligands (APL), by using BIACORE analysis, and solved the crystal structure of H-2D b in complex with the wild-type peptide at 2.75 A Ê resolution. We show that viral escape is due to a 50 to 100-fold reduction in the level of af®nity between the P14 TCR and the binary complexes of the MHC molecule with the different peptides. Structurally, one of the mutations alters a TCR contact residue, while the effect of the other on the binding of the TCR must be indirect through structural rearrangements. The former is a null ligand, while the latter still leads to some central tolerance. This work de®nes the structural and energetic threshold for viral escape.
Introduction
Viruses have developed several mechanisms to escape the immune response of their hosts (reviewed by Zinkernagel, 1996; Borrow & Shaw, 1998; McMichael, 1998) . One of these mechanisms was ®rst revealed in studies on virus mutants, which were no longer cleared in a mouse transgenic for the P14 T-cell receptor (TCR) infected with the lymphocytic choriomeningitis virus (LCMV), in contrast to the wild-type (wt) mouse (Pircher et al., 1990) . These viruses had acquired mutations in T-cell epitopes of the glycoprotein, which abolished recognition by the transgenic cytotoxic T-lymphocytes (CTL). Therefore, the mutation rate of the RNA virus was high enough and the selective pressure created in the transgenic T-cell situation was strong enough such that variants escaping the immune response could emerge.
The same mechanism of escape from CTL control has been demonstrated in other viral infections such as HIV and hepatitis B virus (Bertoletti et al., 1994; Klenerman et al., 1994) . It is interesting that some of these epitopes behaved as antagonists even at substoichiometric ratios relative to the wt epitope (Bertoletti et al., 1994; Klenerman et al., 1994) , while other escape epitopes needed to be present in excess over the wt ligand (Klenerman et al., 1994; Sewell et al., 1997) .
Variant T-cell epitopes, known as altered peptide ligands (APL), have been identi®ed which elicit only part of the spectrum of T-cell responses, or can even antagonize the response to an agonist epitope when presented on the same target cell (reviewed by Sloan-Lancaster & Allen, 1996) . They are identi®ed by differences in the pattern of phosphorylation of ZAP-70 and TCR-associated z-chains (Germain & Stefanova, 1999) . APL epitopes have been isolated both for CD4 and CD8 Tcells (Sloan-Lancaster & Allen, 1996) . Current models favor a discrimination between agonists, weak agonists, partial agonists and antagonists, based on the life-time of the interaction, i.e. the offrate (Davis et al., 1998; Ding et al., 1999; Germain & Stefanova, 1999) .
Several structures of TCRs alone or bound to peptide-MHC complexes (pMHC) have now been solved (reviewed by Garcia et al., 1999; Reinherz et al., 1999) , and provide a basis for understanding the structural basis of cross-reactivity. In particular, Wiley and co-workers have solved crystal structures of four complexes between the same TCR and pMHC complexes harboring either a strong agonist, a weak agonist, or two different weak antagonists (Garboczi et al., 1996; Ding et al., 1999) . The comparison of the structures revealed that cross-reactivity between the ligands was achieved by small structural rearrangements in the peptide, the MHC and the TCR (Ding et al., 1999) . The extent of structural rearrangements, however, did not correlate with the differences in intracellular signaling events (Ding et al., 1999) or the classi®-cation of the peptides as weak agonists or antagonists. The changes induced on the pMHC surface upon going from the wt to an antagonist epitope have also been studied crystallographically by McMichael and coworkers (Reid et al., 1996) . They found essentially three types of structural changes in the pMHC complex: a mere movement of the side-chains exposed to the TCR, conformational changes in the peptidic backbone, and conformational changes in both the peptide and the MHC molecule.
We have investigated here the binding of the recombinant P14 TCR to pMHCs carrying viral epitopes originally isolated in the transgenic mouse model described above, infected with the LCMV virus. Four variants of the immunodominant gp33 epitope, KAVYNFATC, leading to viral escape were described (Pircher et al., 1990) , and we studied the two best characterized ones. These are the peptides V3L (Val3 to Ala), and Y4F (Tyr4 to Phe), respectively.
Here, we have also solved the crystal structure of H-2D b with the wt ligand, which gives a structural basis for understanding the binding of the various peptides to the MHC molecule and to model the effect on TCR recognition. We also extended our study to other APLs, thereby covering the whole range of peptide variants from full agonists to weak agonists and ®nally to antagonist peptides. Our measurements allow us therefore to rank the af®nity of pMHC carrying viral escape epitopes isolated in vivo within the range of af®-nities obtained for APLs identi®ed in vitro and to directly correlate these measurements with current models of T-cell activation. This is, to our knowledge, the ®rst characterization of the af®nities of the TCR for pMHC containing viral escape epitopes.
Results

Expression and purification of MHC and TCR
The pMHC complexes were obtained by expressing the individual subunits in Escherichia coli, and were refolded together with the peptide. They were then puri®ed as described by Tissot et al. (2000) . The TCR was refolded and puri®ed from the a and b-chain expressed individually as inclusion bodies in E. coli, and puri®ed by gel ®l-tration as described (Tissot et al., 2000) .
The pMHC complexes were isolated by gel ®l-tration for all peptides investigated, con®rming that these bind H-2D b , and that the pMHC complexes are stable. This is in agreement with measurements of MHC stabilization by the peptides on RMA-S cells, as determined for the wt as well as the A4Y and F6YT8S epitopes (Bachmann et al., 1996; Sebzda et al., 1996) . The original gp33 protein sequence contains Cys at position 41, but most experiments with isolated peptides were carried out with peptides containing Met at this position, for reasons of stability against air oxidation. We also used the Met peptide in this study (Pircher et al., 1993; Bachmann et al., 1996; Sebzda et al., 1996) . To distinguish the two, we call the Met-containing peptide gp33, and the Cys-containing one gp33c. We solved the crystal structure of the Cys-containing epitope (gp33c). As demonstrated below from a comparison of our structure with the structure of H-2D b in complex with the np366 peptide from the in¯uenza virus (Young et al., 1994) , which contains Met in position P9, both peptides can be used interchangeably. For the V3L and Y4F peptides, binding to the MHC was independently demonstrated in an indirect way in cytotoxic assays, where target cells pulsed with the peptides were killed by CTLs raised against LCMV from C57BL/6 mice (Pircher et al., 1990) , showing that the peptides must have been presented by H-2D b .
SPR measurement
The af®nity between the P14 TCR and the various pMHCs, containing the wt or APLs, was determined by BIACORE measurements. The TCR was non-covalently bound to the sensor chip surface, using an anti-Cb monoclonal antibody, in turn covalently derivatized to the chip (Tissot et al., 2000) . This is equivalent to an af®nity chromatography step, as misfolded and aggregated TCR does not seem to bind, and has the advantage of avoiding loss of activity during regeneration, since new TCR is injected for each measurement. The dissociation of the TCR from the anti-Cb monoclonal antibody is so slow that it is negligible during the plateau phase of pMHC binding. Roughly 4000 RUs of monoclonal antibody were derivatized on the surface. The TCR was injected at a concentration of 0.8 or 1.6 mM, which resulted in the binding of approximately 700 to 1000 RUs. Within each experiment, the variation of the level of TCR bound to the chip at each injection was within 10 % of the average, and appeared to be random, not showing any systematic trend. As described by Tissot et al. (2000) , the binding of the gp33-pMHC to the P14 TCR, in turn bound to the anti-Cb monoclonal antibody on the chip, is speci®c, since other H-2D b complexes containing non-cognate peptides do not bind to the same surface at the same concentration.
The determination of each dissociation constant was performed using the same TCR concentration for immobilization on the anti-Cb monoclonal antibody for all measurements. The pMHCs were then injected on this surface at different concentrations, and as described by Tissot et al. (2000) , the binding of the pMHC to the immobilized TCR rapidly reached equilibrium, which is re¯ected in the plateau shape of the curve. The pMHCs were also injected on an inactivated blank surface as a reference as described by Tissot et al. (2000) . The signal on the reference surface was subtracted from the signal obtained on the TCR surface, to give the corrected signal, which was used to obtain the dissociation constant (K D ). Both the TCR and the reference surface were regenerated after each injection, and fresh TCR was injected for each measurement. Binding of the pMHCs to the anti-Cb monoclonal antibody alone was checked by injecting pMHC over the anti-Cb surface devoid of TCR, and no binding was observed.
The kinetics of the pMHCs injected over the TCR surface and the reference surface was both too fast and at the limit of the instrumental mixing time (Tissot et al., 2000) . Therefore, the dissociation phases of the pMHC injected on either the TCR or reference surface could not be ®tted reliably. Increasing the¯ow rate to 30 ml/min did not affect the difference between the dissociation phases on TCR and reference surface, respectively, indicating that the dissociation phase cannot be obtained with con®dence. Weak interactions between the pMHC and the sensorchip surface lead to a discernable tail (Figure 1(a) ), while BSA injected at the samē ow-rate on the TCR surface displayed an almost perfect``square wave'' form of the kinetics and therefore a much faster kinetics than the pMHC on either the TCR or reference surface. We therefore used the plateau levels for the reliable K D determination for the pMHC/TCR complexes.
Viral escape epitopes
We ®rst investigated the binding of the two variant peptides which were isolated from viruses found to escape the immune response of the host in the transgenic P14 TCR mouse model. These are the Y4F and V3L epitopes. The V3L epitope shows weak binding, which can still be ®tted to a hyperbolic curve (Figure 1(b) , Table 1 ). This results in a saturation binding value of 466 RUs, in agreement, within experimental error, with the value of 550 RUs obtained for the wt epitope on the same surface using the same batch of TCR. The Y4F-pMHC did not show saturation of the signal within the concentration range measured (Figure 1(b) ), re¯ect-ing a very weak binding, and prohibiting any K D determination. In order to obtain an approximation for its K D value, we performed a ®t to a hyperbolic binding curve in which we ®xed the value of RU max to the average RU max value (467 RUs) obtained with the wt, F6YT8S, V3L and Y4A-epitopes containing pMHCs, injected on the same surface and using the same batch of TCR (Table 1) . This yielded a K D value of approximately 680 mM. Changing the value of RU max to the value obtained with the wt-pMHC (550 RUs) raised the K D value to 800 mM, illustrating the range of error inherent to the procedure, but also that the order of magnitude is quite robustly determined. The af®nities of the pMHCs containing both the V3L and Y4F epitopes are therefore 50, and 100-fold lower, respectively, than the af®nity of the P14 TCR for the wt gp33-pMHC (Table 1) . 
The effects of substitutions in the gp33 epitope on the dissociation constant K D and on T-cell activation as measured by cytotoxicity, proliferation, virus clearance and central tolerance. Lysis refers to the ability of the target cell loaded with the corresponding peptide to elicit cytotoxicity when brought in contact with the P14 T-cell clone. Proliferation refers to the ability of the P14 T-cell clone to proliferate when brought in contact with target cells loaded with the corresponding peptide. Virus clearance refers to clearance of the LCMV virus bearing either the wt or mutated glycoprotein containing the mutations of the corresponding peptide in mice infected with the virus. Central tolerance indicates the ability of the LCMV virus bearing the glycoprotein containing either the wt or mutant epitope to induce deletion of the transgenic T-cells in neonatally infected mice. K D is the dissociation constant calculated as described in Materials and Methods and Results. n.d., not determined.
a Determined by BIACORE analysis. b Bachmann et al. (1996) . c Sebzda et al. (1996) . d Pircher et al. (1990) . e Antagonist peptide. An alternative way of ®tting the data could yield a lower K D value, with binding only to a fraction of the molecules (see Results).
Viral escape can thus be rationalized by a dramatic loss of af®nity in the transgenic T-cells consisting of the P14 TCRs to the pMHC complexes containing these epitopes on the target cells. In further agreement with our measurements, central tolerance can be induced to some degree in mice neonatally infected with the V3L-epitope containing virus variant (Pircher et al., 1991) , indicating that the P14 TCR must interact, albeit weakly, with the pMHC containing this epitope. In contrast, target cells pulsed with either of the viral escape epitopes are not lysed by the P14 CTLs (Pircher et al., 1990) (Table 1) , consistent with different thresholds of naive T-cells for negative selection and mature T-cells for activation, when APLs are presented to the T-cells (Sloan-Lancaster & Allen, 1996; Bachmann et al., 1997; Germain & Stefanova, 1999) .
Binding of epitope variants at position 4
In order to put the af®nities determined for the pMHCs containing the viral escape epitopes in perspective, we set out to measure the af®nity of pMHCs containing other altered peptide ligands, which had been studied for the P14 TCR in cellular assays (Bachmann et al., 1996; Sebzda et al., 1996) . The results are shown in Figure 1 (c) and Table 1 . It is surprising that we found the Y4A-pMHC to have a much higher af®nity than the Y4F-pMHC for the P14 TCR, even though replacement of a tyrosine by an alanine residue is more radical a change than the replacement by phenylalanine. Yet, the af®nity of the P14 TCR to the Y4A-containing pMHC is only ®vefold lower than to the wtpMHC complex (Table 1) . Target cells pulsed with this peptide can indeed be lysed by P14 T-cells, which can also be induced to proliferate, although more weakly than by target cells pulsed with the wt epitope . The Y4A epitope has thus been characterized as a weak agonist.
Current models of T-cell activation emphasize the importance of the off-rate of the TCR-pMHC interaction in discriminating between the pharmacological properties of the peptide ligands of the MHC. Assuming that the mutations in the epitopes do not signi®cantly affect the on-rate of the TCRpMHC interaction, a ®vefold decrease in af®nity would result approximately in a ®vefold increase in off-rate, a difference shown by others to be suf®-cient to turn an agonist peptide into a weak agonist or even an antagonist (Davis et al., 1998) .
In contrast, we only detected a weak signal when injecting the Y4S-pMHC on the P14 surface (Figure 1(c) ). As we did for the Y4F-pMHC, we tried to estimate the K D for this APL by constraining RU max to the average obtained on the same chip with the same batch of TCR for the Y4A and the wt-pMHC. We estimated a K D of 530 mM by this procedure (Table 1) . The very low level of binding showed, however, some saturation at low RUs, and we cannot fully exclude that the pMHCs containing this epitope would recognize a minor alternative conformation of the P14 TCR, not equilibrating with the main conformation. This would result in a higher level of af®nity of this pMHC to this type of minor conformer of the TCR, but in the absence of any detectable interaction to the major conformer. The Y4S-peptide has been previously shown to be an antagonist . Recent work has more thoroughly characterized -(®lled triangles) and Y4F-pMHCs (®lled circles) to the P14 TCR, immobilized indirectly on the sensorchip. The error bars were calculated from two measurements. The three pMHCs were measured using the same batch of TCR on the same anti-Cb monoclonal antibody-derivatized sensor chip. The curves were ®tted to a hyperbolic binding curve (equivalent to a Scatchard plot), as described in Materials and Methods. The ®t to the data of the Y4F-pMHC was obtained by taking the average value of RU max obtained with four different pMHCs, as described in Results, on the same surface and using the same batch of TCR. Each dissociation constant was measured in two independent experiments. An RU max of 550 for the wild-type is obtained from the ®t, and the highest experimentally determined point is at 87 % saturation. (c) Binding isotherm of the wt-(open circles) , Y4A-(®lled triangles) and Y4S-pMHCs (®lled circles). The three pMHCs were measured using the same batch of TCR on the same anti-Cb monoclonal antibody-derivatized sensor chip. The curves were ®tted to a hyperbolic binding curve, as described in Materials and Methods. The ®t to the data of the Y4S-pMHC was obtained by taking the average value of RU max obtained with the Y4A-and wt-pMHC, as described in Results, on the same surface and using the same batch of TCR. Each dissociation constant was measured in two independent experiments. An RU max of 814 for the wild-type is obtained from the ®t, and the highest experimentally determined point is at 93 % saturation.
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the mechanism of action of this peptide, and shown that it antagonizes T-cell proliferation and TCR down-regulation at high concentration and in high molar excess over the wt peptide (Bachmann et al., 1998) . In fact, Y4S was postulated to be the peptide leading to the weakest interaction between P14 TCR and pMHC out of a series of antagonists. This is in agreement with the low af®nity we have found for the interaction between the Y4S-pMHC and P14 TCR.
We have included another peptide, the F6Y/T8S double mutant epitope, in our analysis (Table 1) . This epitope was shown to be able to induce the full spectrum of T-cell responses, although somewhat more weakly than the wt epitope (Bachmann et al., 1996) . We have found a twofold lower af®-nity of the P14 TCR for the pMHC containing this epitope. In summary, we ®nd a strong correlation between the af®nity of the P14 TCR for the pMHCs containing the APLs, and the corresponding T-cell responses induced by these ligands, as well as with their classi®cation as agonist, weak agonist or antagonist (Table 1) , (Pircher et al., 1990; Bachmann et al., 1996; Sebzda et al., 1996) .
Crystal structure of the pMHC complex
We determined the pMHC structure with wt gp33c peptide, KAVYNFATC, at 2.75 A Ê resolution in the spacegroup P2 1 (Figure 2(a) and (b) , Table 3 ). The overall structure of H-2D b is very similar to the published structure of H-2D b with the in¯uen-za virus np366 peptide ASNENMETM (Young et al., 1994) . Superposition of the C a atoms of the a1/a2 domains in the two structures gives a rmsd of 0.55 A Ê . The gp33c peptide, shown in Figure 2 (b) with its electron density, adopts an extended conformation and arches at P6 and P7 over the MHC due to the presence of a hydrophobic ridge which cuts across the binding site (Figure 2(b) ) (Young et al., 1994) . Side-chains P1, P4, P6, P7 and P8 are solvent accessible, and thus available for interaction with the TCR (Figure 2 Table 2 (Collaborative Computational  Project Number 4, 1994; McDonald & Thornton, 1994) .
It is worth mentioning that modeling of the gp33 peptide in the H-2D b -binding cleft (Lewicki et al., 1995) , based on the np366/H-2D b crystal structure (Young et al., 1994) , had allowed the prediction of the solvent-exposed residues, and the identi®cation of their approximate orientation. On the other hand, in the modeled structure Lewicki et al. (1995) drastically changed the P6 É dihedral angle to allow for the Met to Phe substitution, and avoid a clash with the walls of the binding site. Our X-ray structure shows instead that such a change happens to a much smaller extent; rather, the bulkier Phe side-chain is accommodated in a minor shallow pocket on the H-2D b surface (Figure 2(a) ), and the main-chain is shifted towards the a2-helix. As a result, the distance between the two P6 C a atoms, after superimposing the a1/a2 domains, is 1.45 A Ê .
Superposition of the gp33c peptide with the two other peptides containing the canonical anchor Asn in position P5 (Falk et al., 1991) in complex with H-2D b , namely the above-mentioned np366 peptide (Young et al., 1994) and the Sendai virus peptide FAPGNYPAL (Glithero et al., 1999) (Figure 3(a) ), gives comparable rms deviation values for the C a atoms. These values vary from 0.58 A Ê for the np366-Sendai virus pair, 0.75 A Ê for the gp33c-np366 pair, and ®nally to 0.90 A Ê for the gp33c-Sendai virus pair. The highest rms distance is observed for the P6 residue, ranging from 1.45 A Ê to 2.30 A Ê for the three pairwise comparisons. All the above-mentioned values are calculated after superimposing the a1/a2 H-2D b domains. This striking conformational variability at P6 is con®rmed by an analysis of the f-c dihedral angles. The value of f for P6 varies between À107 and À89
, while c varies from À124 to À42 : this is the highest variation found for the nine peptide residues. Furthermore, despite the similarity between the two P6 side-chains Phe and Tyr, in the gp33c and Sendai virus peptides, respectively, these residues contribute a considerably different portion of the total solvent exposed surface of the respective peptides: 78 A Ê 2 out of a total of 291 A Ê 2 (27 %) for gp33c (Table 2) , and 148 A Ê 2 out of 256 A Ê 2 (58 %) for the Sendai virus.
Our analysis suggests that the presence of the hydrophobic ridge has the effect of locally increas- . The view is from the a2-helix side of the MHC class I heavy chain. The a1-helix lies behind the peptide, and the a2-helix has been removed for clarity. The b-sheet forms the¯oor of the binding site. The 2F o À F c map is contoured at 1.2 s level. Figure 2 (b) was generated with SETOR (Evans, 1993) .
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ing the variability of the peptide conformation. The hydrophobic ridge is comprised of residues Trp73, Trp147 and Tyr156. Trp147 N e1 forms a conserved hydrogen bond with the main-chain carbonyl oxygen atom of P8 in all three structures (Figure 3(b) ); however, a different hydrogen bond pattern occurs with the other two residues. Trp73 N e1 is hydrogen-bonded to the P6 main-chain carbonyl oxygen atom in the gp33c structure, but rather binds to the P7 main-chain oxygen atom in the other two structures. Conversely, the P7 mainchain oxygen atom of gp33c makes an additional interaction, via a water molecule, with the hydroxyl group of Tyr156 (Figure 3(b) ).
In the structure of H-2D b in complex with the np366 peptide from in¯uenza virus (Young et al., 1994) , the F pocket (Saper et al., 1991) is occupied by a Met residue in position P9, while our structure contains a Cys residue at this position. Both sidechains contribute hydrophobic interactions to the overall binding. The larger Met side-chain reaches to the end of the pocket, interacting with Phe116, while the Cys side-chain interacts with Ser77 at the rim of the pocket (Figure 4(a) ). Three hydrogen bonds between the peptide C-terminal carboxylate group and the H-2D b residues Asn80, Tyr84, and Thr143 are conserved. The rms distance for the C a of the two residues (0.12 A Ê ) clearly demonstrates that the peptide conformation at the C terminus is independent of the presence of Cys or Met in P9, and thus both residues can be used interchangeably, as can be seen from their structural superposition (Figure 4(a) ). Careful visual inspection of the B, C, D and F pockets in the structure, and comparison with the two other structures of H-2D b (Young et al., 1994; Glithero et al., 1999) using the program O (Jones et al., 1991) , did not reveal signi®cant structural changes of the side-chains lining these pockets, but mere local rearrangements.
Discussion
Recognition of gp33-pMHC by P14 TCR
A striking feature of the interaction between the gp33-pMHC and the P14 TCR is the strong dependence of the af®nity on the nature of the residue at The superposition of the gp33c-(yellow) and Sendai virus-(green) pMHCs, based on the C a positions of the a1a2 MHC domains, shows the different network of hydrogen bonds formed by the hydrophobic ridge residues. The two structures are seen from the solvent accessible side, with both peptide main-chains running from left to right. The hydrogen bonds are represented as broken lines, and the water molecule as a sphere. Figure 3 was generated with SETOR (Evans, 1993) . position 4. This residue is freely accessible for the TCR, as seen in the structure (Figure 2(a) ), and contributes the most to the accessible surface of the peptide (Table 2) , which is in agreement with its predominance in the interaction between the P14 TCR and the gp33-pMHC. Although it is common for pMHC-TCR interactions to be dominated by the contribution of only a few residues (Garcia et al., 1999) , we have here the extreme case where removal of a single hydroxyl group, by introducing a phenylalanine for a tyrosine residue, completely abolishes the interaction with a hundred-fold reduction in af®nity. It is more surprising that the far less conservative replacement of tyrosine by an alanine residue leads to a much smaller reduction in af®nity, while substitution of the tyrosine residue to serine also shows a dramatic reduction in binding. Although no quantitative binding data are available, a tyrosine to valine substitution at this position has also been investigated (Bachmann et al., 1998) . The data on cell lysis or T-cell proliferation obtained for this ligand show also the typical pattern of a weak interaction, much weaker than for the alanine substituted peptide (Bachmann et al., 1998) . Tyr at position 4 is therefore best replaced by alanine. This suggests that the TCR ®nds an alternate mode of binding to the pMHC with Ala at position 4 which cannot be explained by a static picture. The generation of unsatis®ed hydrogen bond partners and steric constraints or induced ®t are likely to play a major role. This is in agreement with the concept of a``functional hot spot'', as demonstrated in the crystal structure of the complex of the 2C TCR and the SIYR/H-2 K b pMHC (Degano et al., 2000) .
On the other hand, we do not ®nd such a strong dependence of the interaction on the residues at position 6 and 8, which are facing outwards in the structure as well (Figure 2(a) , Table 2 ), since the F6Y/T8S peptide leads only to a small decrease in af®nity of the corresponding pMHC for the P14 TCR. However, there might be compensating effects between the two sites, and a more detailed analysis would be needed to assess the importance of these side-chains for the interaction with the TCR. Lewicki et al. (1995) found a complete abrogation of CTL lysis when introducing single alanine residue substitutions at position 6 and 8 in the gp33 epitope, strongly suggesting their importance in TCR recognition.
Structural alignment of a homology model of the P14 TCR (A. Honegger, unpublished results) and the structure of the gp33c-pMHC with the two published TCR-pMHC complexes resulted in numerous clashes between TCR and pMHC atoms. The pMHCs were aligned on the conserved a1 and a2-helices, and the TCRs on their framework residues. The way a TCR interacts with a pMHC of known structure is therefore too intricate and complex to be predicted by a simple structural alignment procedure, and the structure has to be solved each time.
Substituting valine for leucine at position 3 of the peptide also leads to a dramatic decrease in af®nity for the TCR (Table 1, Figure 1(b) ), although residue 3 is buried within the MHC (Figures 2(b) , . The simulated V3L peptide is shown in green. The molecular surface of the MHC class I molecule is shown in arbitrary colors, and was produced using GRASP (Nicholls et al., 1991) .
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4(b)). Val3 binds to the D pocket of H-2D
b , according to the nomenclature by Saper et al. (1991) . This pocket is lined by Ser99, Leu114, Tyr156, and Tyr159, and is mostly hydrophobic in nature, with the interaction between the peptide and the protein being dominated by the hydrophobic contact between P3Val and Tyr159 (Figure 4(b) ). The substitution of Val to the bulkier Leu residue most probably leads to a clash with the pocket residues and induces a shift of the peptide chain, which in turn alters the interaction with the TCR. This was tested by introducing the relevant mutation into the experimental structure, and carrying out a conjugate gradient minimization using CNS (Bru È nger et al., 1998), excluding the experimental energy terms and allowing the pocket residues as well as the P2 to P4 peptide residues to move (Figure 4(b) ). Small but signi®cant movements of the peptide backbone and side-chains were revealed (Figure 4(b) ). Overall, these rearrangements in the pMHC-complex explain the 50-fold reduction in af®nity to the TCR.
Mutations in the virus which lead to escape from the immune system, most likely abolish recognition by two mechanisms in our case: either by affecting a residue directly in contact with the TCR, in our case residue P4, or by affecting more indirectly recognition through conformational changes in the peptide or the MHC. These two mechanisms have been demonstrated in crystallographic studies on pMHC and TCR-pMHC complexes containing altered peptide ligands (Reid et al., 1996; Ding et al., 1999) . Here, we have been able to quantify the effect of these structural changes on the af®nity of the interaction between TCR and pMHC containing viral escape epitopes.
Using the V3L epitope an interesting phenomenon was observed which had originally been described for antibodies, termed the``original antigenic sin'' (Klenerman & Zinkernagel, 1998) . Mice primed with the virus carrying the wt epitope respond to a subsequent infection with viruses carrying the variant epitope with a CTL response targeting the wt epitope, rather than the variant epitope (Klenerman & Zinkernagel, 1998) . By providing a measure of the af®nity of the pMHC carrying this ligand to the P14 TCR, we show here that, although the af®nity of the TCR for this pMHC is reduced 50-fold compared to the pMHC containing the wt epitope (Table 1) , a speci®c interaction still occurs. This would support the interpretation proposed by Klenerman & Zinkernagel (1998) that the interaction between the TCRs recognizing the wt peptide and pMHCs carrying the variant ligand would still result in positive selection of thymocytes directed against the wt epitope, and may also provoke CTL expansion in the periphery.
Antagonist ligands
T-cell activation is thought to be controlled by the kinetics of the TCR-pMHC interaction, whereby the off-rate of this interaction discriminates between an agonist, weak agonist or antagonist peptide (Davis et al., 1998; Grakoui et al., 1999) . Antagonist ligands have been postulated to interfere with the productive clustering of the signaling TCRs, thereby either preventing the accumulation of positive signals, or even inducing negative signals (Germain & Stefanova, 1999) . pMHCs on APCs have been found to serially engage and activate TCRs, leading to their down-modulation (Valitutti et al., 1995) . In this context, antagonism has been suggested to act by reducing the amount of TCRs available for signaling below a certain critical threshold (Lanzavecchia et al., 1999) . Furthermore, a hierarchy of T-cell activation has been observed, where responses such as cytotoxicity or T-cell proliferation for a given ligand have been shown to have different requirements in terms of ligand concentration (Sloan-Lancaster & Allen, 1996; Valitutti et al., 1996; Bachmann et al., 1997; Germain & Stefanova, 1999) .
Recently, Grakoui et al. (1999) have shown, using the cluster density of pMHCs as a readout, that this parameter correlated best with the half-life of the TCR-pMHC interaction determined by BIA-CORE, when comparing data from two different TCR systems. They used an experimental set-up in which T-cells interacted with pMHCs embedded in a glass-supported planar bilayer. Within one TCR system, cluster density also correlated with the dissociation constant. This indicates that the mutations within the peptide ligands primarily affect off-rates and the on-rates are therefore rather constant, as is typical for most protein-ligand interactions. Consistent with these ®ndings, the 50-fold and 100-fold reductions in af®nity of the viral escape mutants found here would also be expected to correspond to an equivalent increase in off-rate, explaining the lack of T-cell response found for these peptide ligands. The APL Y4A has been classi®ed as a weak agonist. We have found only a ®vefold decrease in the level of af®nity for the TCR. The relatively high af®nity of the pMHC containing this peptide is re¯ected well in cellular assays for antagonism, where high concentrations of this ligand do not inhibit T-cell proliferation or cytotoxicity but rather increase it, showing that this ligand is not an antagonist (Bachmann et al., 1998) . As the Ala4-containing peptide has a far higher level of af®nity than any other mutation at this position, we must conclude that the introduction of the minimal-length alanine side-chain does not induce a conformational disturbance of the complex, in contrast to other residues.
Conclusions
We provide, for the ®rst time, a measure of the af®nity between pMHCs containing viral escape ligands and their TCR. We have characterized two types of escape epitopes. One is a null ligand (Y4F), while the other (V3L) is still able to induce central tolerance to some extent, and may as well provoke CTL expansion in the periphery. Furthermore, we provide af®nity data on weak agonist and antagonist ligands with which the viral escape ligands can be compared. We ®nd that these ligands are within the af®nity range expected for antagonist or null peptides. In this respect, it will be interesting to ®nd out whether the viral escape epitopes analyzed here can function as antagonists of the wt ligand, and if so, whether they act only when in excess over the wt ligand or already substoichiometrically. In summary, agonists, weak agonists and antagonists are peptides which are characterized by the magnitude of interaction energy (re¯ected in af®nity and off-rate). Below a critical threshold, suf®cient TCR clustering can no longer occur. The virus, however, has several options to achieve this type of mutation. A variant can be selected which directly targets the most exposed residue, or which can disturb the interaction of the peptide with the MHC. In this respect, alteration of epitope side-chains interacting with small pockets of the MHC are more likely to result in escape than truncation of side-chains interacting with large pockets. It appears that a reduction in af®nity to about 500 mM K D provides a safe viral escape, which can be achieved with a variety of single point mutations.
Materials and Methods
The peptides were synthesized and puri®ed by Chiron Technologies (Clayton Victoria, Australia) to 95 % purity and analyzed by mass spectrometry. The peptides had the following sequences 
Expression and purification of TCR and pMHC
The TCR and pMHC complexes were expressed, refolded and puri®ed as described by Tissot et al. (2000) . The TCR was refolded by dialysis against 20 volumes of 0.4 M arginine-HCl, 20 mM Tris-HCl (pH 8.0) and subsequently dialyzed against 20 mM Tris-HCl, 150 mM NaCl (pH 8.0). It was then puri®ed by three runs of gel ®ltration over a Superdex G200 column (Amersham Pharmacia Biotech) (Tissot et al., 2000) .
The pMHCs were refolded as described, except for the gp33-pMHC with cysteine, which was refolded in a buffer containing 0.8 M arginine-HCl, 200 mM Tris-HCl, 2 mM EDTA, 1 mM oxidized L-glutathione and 5 mM reduced L-glutathione (pH 7.5). Except for the MHC/ gp33c complex, which was puri®ed by anion exchange chromatography (Tissot et al., 2000) , all of the pMHCs were puri®ed by two runs of gel ®ltration on a Superdex G-75 column (Amersham Pharmacia Biotech). The protein concentrations were determined by spectrophotometry (Gill & von Hippel, 1989) .
Surface plasmon resonance
All measurements were performed on a BIACORE instrument (BIACORE AB, Uppsala, Sweden) as described by Tissot et al. (2000) . In brief, the TCR was non-covalently bound to the anti-Cb antibody H57-597 (Kubo et al., 1989) , which in turn was covalently derivatized on the chip. Both the TCR-containing surface and control surfaces were regenerated with 0.1 M glycine/ HCl, 500 mM NaCl (pH 2.5) after each injection. The signal was calculated by subtracting the signal obtained on a deactivated control surface from the signal obtained on the TCR surface. Each data point was the average of two measurements. The dissociation constant was obtained by plotting (KaleidaGraph 3.08, Synergy Software, Reading, PA) the signal in RUs against the concentration of the injected pMHC, and ®tting it to a hyperbolic curve, RU RU max Â [pMHC]/(K D [pMHC] ), where RU max is the maximal value at saturation. Each dissociation constant was measured in two independent experiments.
Crystallization, X-Ray data collection, structure solution, and refinement
Crystals of the H-2D
b /gp33c complex were grown by the hanging drop vapor diffusion method at 4 C. Two microliters of protein solution, containing a 1:1 molar ratio of MHC/peptide (at a total protein concentration of 5.85 mg/ml), was mixed with 1 ml of reservoir solution; the reservoir solution contained 0.1 M ammonium sulfate, 20 % (w/v) PEG 4000, 0.1 M Hepes buffer (pH 7.4), and 0.02 % (w/v) sodium azide. Prior to data collection, the crystals were transferred into a buffer containing the reservoir solution enriched with 20 % (v/v) glycerol, and ash-frozen in a stream of liquid nitrogen at a temperature of 100 K. A 91 % complete dataset at 2.75 A Ê resolution was collected from a single crystal, using an Enraf Nonius CuK a rotating anode X-ray source, equipped with double focusing mirrors (MacScience). The data were processed and scaled using the HKL suite of programs (Otwinowski & Minor, 1997) . The crystals belong to the primitive monoclinic spacegroup P2 1 . Structure determination was carried out using the molecular replacement method with the program AMoRe (Navaza, 1994) , using the H-2D b /p1027 complex (Zhao et al., 1999) (RCSB Protein Data Bank code 1bz9) as a search model, after removal of the peptide. The structure solution indicated the presence of four complexes in the asymmetric unit. Two strong cross-rotation function peaks were found, and the subsequent translation function search detected a total of four strong peaks. These peaks identi®ed four molecules, two of which had independent orientations, while the other two were related to the ®rst pair by simple translation. Fast rigid-body re®nement of the four solutions of the rotational and translational search gave a correlation coef®cient of 57.4 %, and an R factor of 48.8 %. Independent rigid-body re®nement of the heavy chain and b 2 -microglobulin was then performed using CNS (Bru È nger et al., 1998) . Afterwards, cycles of structure re®nement in CNS, using strong non-crystallographic symmetry restraints (300 kcal mol À1 A Ê À2 ), were alternated with manual rebuilding of the model in O (Jones et al., 1991) . Simulated annealing was utilized in the early stages of re®nement. The peptide was introduced as a poly-alanine model after the R factor Viral Escape at the Molecular Level and R free had decreased below 28 % and 30 % respectively, and the appropriate residues were introduced in later stages. Grouped B-factor re®nement was initially performed using one value per residue, and towards the end of re®nement two B values were re®ned, one for the backbone atoms and one for the side-chain atoms. Fourfold non-crystallographic symmetry average maps produced with the program DM (Cowtan, 1994) were used throughout the model-building process. The ®nal R factor and R free were 23.6 % and 27.6 %, respectively. The crystallographic statistics are presented in Table 3 .
